Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galphimia glauca extract vs Alprazolam in GAD
NCT03702803Phase 2Unknown
- Sponsor
- Coordinación de Investigación en Salud
- Start
- Mar 2016
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of galphimia glauca in generalized anxiety disorder (GAD), sponsored by Coordinación de Investigación en Salud. Status: unknown.
02
Drugs
galphimia glauca
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT03702803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03702803.